Carlsberg A/S B (0AI4)
London Exchange · UK · prices in DKK · close of 19 Oct 2026
Key indicators
| Last close | DKK 945.70 |
|---|---|
| 52-week range | 729.74 – 981.82 |
| Return, 1 month / 3 months | +12.4% / +2.4% |
| Return, 1 year / 3 years | +25.9% / +14.7% |
| Trend | Uptrend |
| RSI (14) | 75 |
| Volatility (1 year) | 23.0% |
| Worst drawdown (1 year) | -18.5% |
| Average daily value traded | 55.22M DKK |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Carlsberg is a Danish brewing company based in Copenhagen that makes and sells beer and other beverages. Its brands include Carlsberg and Tuborg, along with many local beer names brewed in the countries where it operates. The company supplies supermarkets, shops, bars, restaurants and other outlets, and it also produces soft drinks and water in some markets. Its business spans Europe, Asia and other regions, with brewing done close to the customers it serves.
The shares are listed on the London Exchange in UK under the code 0AI4, and the price on this page is in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Carlsberg A/S B (0AI4) trades on the London Exchange in UK. It last closed at DKK 945.70 on 19 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 405 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 25.9% and over the last three months it rose 2.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.4% | ||
| From 52-week high | -2.4% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.4% | ||
| 6-month return | 12.9% | ||
| 12-month return, skipping the last month | 12.0% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.5% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 55.22M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +5.6% |
|---|---|
| 1 month | +12.4% |
| 3 months | +2.4% |
| 6 months | +12.9% |
| 1 year | +25.9% |
| 3 years | +14.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 880.72 / 872.43 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 17.99 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Mar 2026 | DKK 29.0000 |
| 18 Mar 2025 | DKK 27.0000 |
| 12 Mar 2024 | DKK 27.0000 |
| 14 Mar 2023 | DKK 27.0000 |
| 15 Mar 2022 | DKK 24.0000 |
| 16 Mar 2021 | DKK 22.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.